Drug intelligence / Profile preview

blomia tropicalis allergen extract

Development stage
Phase 2
Lead developer
BioCen
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual, Intradermal, Epicutaneous
01

Overview

Blomia tropicalis allergen extract is a biological product derived from the house dust mite *Blomia tropicalis*, which is a primary source of allergens in tropical and subtropical regions. This extract is used for both allergy diagnosis and as a therapeutic agent in allergen immunotherapy (AIT). [5, 14, 18] For diagnosis, it is applied via skin prick tests to identify sensitization in individuals suffering from allergic asthma and rhinitis. [5, 11] As a therapy, the extract is administered, typically via subcutaneous injection, in gradually increasing doses to induce immunological tolerance and reduce the allergic response to the mite. [11] Clinical studies have demonstrated that AIT with *Blomia tropicalis* extract is safe and effective in diminishing symptoms and medication dependency in patients with allergic asthma. [3, 11]

Brand names
VALERGEN-BT
Other names
Blomia tropicalis allergenic extractstandardized allergen vaccine of B. tropicalisBTH2BTH-2BTH 2
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on blomia tropicalis allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on blomia tropicalis allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call